All research
Oxytocin 2017-03-03 ClinicalTrials

Oxytocin's Differential Effects on Behavior and Neural Indices Explored in High vs. Low Trait Anxiety Males

Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety

Background

Trait anxiety is a stable personality characteristic marked by chronic worry and heightened physiological arousal, even without immediate threats. Individuals with high trait anxiety often exhibit hyper-connectivity in brain defensive networks, contributing to their persistent anxiety proneness. Current treatments may not fully address these intrinsic neural patterns. Oxytocin, a neuropeptide known for its roles in social bonding and stress modulation, is being investigated for its potential to influence anxiety-related behaviors and neural circuits, particularly in populations with varying anxiety levels.

Study Design

This randomized study enrolled 131 healthy male subjects, stratified into high or low trait anxiety groups based on initial assessment. Participants received multiple oral doses of oxytocin or placebo. The primary objective was to examine differential effects of oxytocin on behavior and neural indices, including interest in social stimuli, across these anxiety groups. The study design aimed to identify dose-dependent effects of oxytocin treatment on these outcomes, utilizing various visual attention paradigms and neural imaging techniques.

Results

The provided abstract details the study's aims and methodology but does not present any specific findings, numerical results, or statistical significances. The investigation was designed to assess whether multiple doses of oxytocin would differentially impact behavioral measures, such as interest in social stimuli, and neural indices across groups of males with high versus low trait anxiety. The study intended to explore dose-dependent effects on these outcomes, likely utilizing measures from visual attention paradigms and neuroimaging. However, no data regarding observed changes in behavior, neural activity, or any comparative results between the high and low anxiety groups, or between oxytocin and placebo arms, are reported within this abstract. Consequently, no specific percentages, p-values, or fold-changes can be extracted or reported.

Why It Matters

Understanding how oxytocin interacts with varying levels of trait anxiety could pave the way for more personalized therapeutic strategies for anxiety disorders. If differential effects are confirmed, it suggests that oxytocin interventions might be most effective, or require specific dosing, for individuals within certain anxiety profiles. This research could refine future clinical protocols, potentially guiding the selection of patients who would benefit most from oxytocin-based treatments or informing optimal dosing regimens. Identifying specific biomarkers or anxiety subtypes responsive to oxytocin could significantly improve treatment efficacy and reduce trial-and-error approaches in anxiety management. While this study is foundational, positive findings would move us closer to targeted pharmacological interventions that leverage oxytocin's neuromodulatory properties.


oxytocin trait anxiety anxiety neuroscience human study randomized controlled trial
Source: clinicaltrials:NCT03085654 · Ingested 2026-07-10 · Digest: gemini-2.5-flash